The value of serum FGF-23 as a cardiovascular marker in HD patients
المؤلفون المشاركون
Abd al-Rahman, Muhammad
al-Shahawy, Yasir
Aziz, Ahmad
Sani, Dawlat
al-Sawi, Abd al-Basit
Ahmad, Hayam
Arif, Hayam
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 25، العدد 1 (28 فبراير/شباط 2014)، ص ص. 44-52، 9ص.
الناشر
تاريخ النشر
2014-02-28
دولة النشر
السعودية
عدد الصفحات
9
التخصصات الرئيسية
الموضوعات
الملخص EN
-Fibroblast growth factor 23 (FGF-23) is a recently discovered regulator of phosphate and mineral metabolism and has been associated with both progression of CKD and mortality in dialysis patients.
To evaluate the association between serum FGF-23 levels and echocardiographic measurements in long-term HD (HD) patients without cardiac symptoms, we studied 90 consecutive patients treated in a single HD center (51 males, 39 females; mean age 41.5 ± 14.2 years, mean HD duration 71.2 ± 14.2 months).
Comprehensive echocardiography was performed after HD and blood samples were obtained before HD.
The serum FGF-23 level in dialysis patients was 95.7 ± 88.4 pg/mL.
In univariate analysis, serum calcium levels (r = 0.33, P <0.05), serum creatinine (r = 0.34, P <0.05), serum albumin (r = 0.35, P <0.05) and left ventricular mass index (LVMI) (r = 0.33, P <0.001) were correlated weakly with the FGF-23 levels.
Neither s.
phosphorus nor calcium x phosphorus product correlated with FGF-23.
In univariate regression analysis, only LVMI [β = 0.42, P <0.05, confidence interval (CI) 0.3–4.3], serum calcium (β = 0.87, P <0.001, CI 0.8–7.3), serum albumin (β = 0.87, P < 0.001, CI 0.8–7.3) and serum creatinine (β = 0.67, P <0.05, CI 0.5–6.5) significantly correlated with FGF-23.
FGF-23 was identified as a factor that is weakly associated with LVMI.
Thus, FGF-23 alone may not be a parameter that can be used for evaluation of the cardiac status in HD patients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Sani, Dawlat& al-Sawi, Abd al-Basit& Aziz, Ahmad& al-Shahawy, Yasir& Ahmad, Hayam& Arif, Hayam…[et al.]. 2014. The value of serum FGF-23 as a cardiovascular marker in HD patients. Saudi Journal of Kidney Diseases and Transplantation،Vol. 25, no. 1, pp.44-52.
https://search.emarefa.net/detail/BIM-356556
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Sani, Dawlat…[et al.]. The value of serum FGF-23 as a cardiovascular marker in HD patients. Saudi Journal of Kidney Diseases and Transplantation Vol. 25, no. 1 (Jan. / Feb. 2014), pp.44-52.
https://search.emarefa.net/detail/BIM-356556
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Sani, Dawlat& al-Sawi, Abd al-Basit& Aziz, Ahmad& al-Shahawy, Yasir& Ahmad, Hayam& Arif, Hayam…[et al.]. The value of serum FGF-23 as a cardiovascular marker in HD patients. Saudi Journal of Kidney Diseases and Transplantation. 2014. Vol. 25, no. 1, pp.44-52.
https://search.emarefa.net/detail/BIM-356556
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 50-52
رقم السجل
BIM-356556
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر